ALPS Advisors’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-87,463
| Closed | -$945K | – | 1003 |
|
|
2024
Q3 | $945K | Buy |
87,463
+12,865
| +17% | +$139K | 0.01% | 508 |
|
|
2024
Q2 | $629K | Buy |
+74,598
| New | +$629K | ﹤0.01% | 547 |
|
|
2023
Q2 | – | Sell |
-46,045
| Closed | -$497K | – | 1010 |
|
|
2023
Q1 | $497K | Sell |
46,045
-1,335
| -3% | -$14.4K | ﹤0.01% | 593 |
|
|
2022
Q4 | $548K | Buy |
47,380
+11,479
| +32% | +$133K | ﹤0.01% | 574 |
|
|
2022
Q3 | $536K | Buy |
35,901
+8,720
| +32% | +$130K | 0.01% | 578 |
|
|
2022
Q2 | $245K | Sell |
27,181
-13,779
| -34% | -$124K | ﹤0.01% | 951 |
|
|
2022
Q1 | $307K | Sell |
40,960
-5,156
| -11% | -$38.6K | ﹤0.01% | 763 |
|
|
2021
Q4 | $396K | Buy |
+46,116
| New | +$396K | ﹤0.01% | 671 |
|